ATAD3A and Cognitive impairment: Therefore, inhibition of ATAD3A oligomerization by DA1 reduced the AD neuropathology and cognitive deficits manifested in 5XFAD mice, consistent with our observations made in heterozygous ATAD3A knockout 5XFAD mice (Fig. 3; Supplementary Fig. 4).